01140nam0 2200277 450 00003443620220511145917.0978-88-9357-357-320220511d2022----km-y0itay50------baitaITa-------001yyOrganizzare la conoscenza: Digital Humanities e Web semanticoun percorso tra archivi, biblioteche e museiFrancesca TomasiMilanoEditrice Bibliograficac2022183 p.21 cmBiblioteconomia e scienza dell'informazione392001Biblioteconomia e scienza dell'informazioneOrganizzare la conoscenza: digital humanities e web semantico2835087Elaboratori elettroniciImpiego nelle scienze umane001.3028522Discipline umanistiche. Elanorazione dei dati applicazioni dell'elaboratoreTomasi,Francesca168473ITUNIPARTHENOPE20220511RICAUNIMARC000034436001-O/1s.i.NAVA12022Organizzare la conoscenza: digital humanities e web semantico2835087UNIPARTHENOPE01166nam 2200325Ia 450 99638313760331620221108034538.0(CKB)1000000000598455(EEBO)2240896054(UnM)99900630(EXLCZ)99100000000059845519990302d1602 uy |engurbn||||a|bb|The history of the Bible[electronic resource] briefly collected by way of question and answere. Read and corrected by the author[London] Printed by Iohn Legat, printer to the Vniuersitie of Cambridge. 1602. And are to be sold in Pauls Churchyard at the signe [of] the Crowne by Si. Waterson[1602][4], 304 pBy Eusebius Pagit.Place of publication from STC.Lacks pages 169-170.Reproduction of original in the Folger Shakespeare Library.eebo-0055Pagit Eusebius1547?-1617.1009342Cu-RivESCu-RivESWaOLNBOOK996383137603316The history of the Bible2355363UNISA03690nam 2200637Ia 450 991078265510332120230721004539.00-309-17865-71-281-80023-697866118002390-309-10743-1(CKB)1000000000705282(EBL)3378407(SSID)ssj0000097237(PQKBManifestationID)11122248(PQKBTitleCode)TC0000097237(PQKBWorkID)10113248(PQKB)11492283(MiAaPQ)EBC3378407(Au-PeEL)EBL3378407(CaPaEBR)ebr10255035(CaONFJC)MIL180023(OCoLC)923279359(EXLCZ)99100000000070528220080917d2008 ua 0engur|n|---|||||txtccrAddressing the barriers to pediatric drug development[electronic resource] workshop summary /Cori Vanchieri, Adrienne Stith Butler, and Andrea Knutsen, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National AcademiesWashington, D.C. National Academies Pressc20081 online resource (65 p.)Description based upon print version of record.0-309-10742-3 Includes bibliographical references (p. 41-42).""Reviewers""; ""Contents""; ""Summary""; ""1 Introduction""; ""2 Regulatory Framework""; ""3 Current Challenges in Developing and Prescribing Drugs for Children""; ""4 Models for Enhancing Pediatric Drug Development""; ""5 Challenges and Opportunities for the Future""; ""References""; ""Appendixes""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker Biographies""Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children--50 to 75 percent-- have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.DrugsTestingLaw and legislationUnited StatesPediatric pharmacologyLaw and legislationUnited StatesPediatric pharmacologyResearchUnited StatesDrugsTestingLaw and legislationPediatric pharmacologyLaw and legislationPediatric pharmacologyResearch615.58083Butler Adrienne Stith1470578Knutsen Andrea1578442Vanchieri Cori1546613Institute of Medicine (U.S.).Forum on Drug Discovery, Development, and Translation.MiAaPQMiAaPQMiAaPQBOOK9910782655103321Addressing the barriers to pediatric drug development3857766UNINA